Kimryn Rathmell, CEO of Ohio State’s James Cancer Hospital and Solove Research Institute, shared a post on LinkedIn:
“Look out for Christian Rolfo at ASCO25! He’s the quintessential triple threat – impacting precision-based patient care from the biology, translation, and drug development in cancer, and he directs the Division of Medical Oncology at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute. Here’s a great article to tell you about his journey and the impact he’s having on cancer.”
More posts featuring Kimryn Rathmell.